Releases


All 2017 Releases
Sep 30, 2017 Veloxis Announces the Total Number of Shares and Voting Rights in the Company as of 30 September 2017 PDF 207.3 KB Add to Briefcase
Sep 20, 2017 Alastair McEwan Steps Down as Chief Operating Officer of Veloxis Pharmaceuticals A/S PDF 173.7 KB Add to Briefcase
Sep 13, 2017 Veloxis Pharmaceuticals, Inc., Appoints Ulf Meier-Kriesche, MD, as Chief Scientific Officer PDF 174.6 KB Add to Briefcase
Sep 12, 2017 Veloxis Increases Share Capital in Connection with Exercise of Warrants PDF 253.0 KB Add to Briefcase
Aug 16, 2017 Veloxis Pharmaceuticals Announces Financial Results for the First Six Months of 2017 PDF 447.8 KB Add to Briefcase
Jul 3, 2017 Veloxis Announces the Total Number of Shares and Voting Rights in the Company as of 30 June 2017 PDF 207.0 KB Add to Briefcase
Jun 21, 2017 Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program PDF 225.2 KB Add to Briefcase
Jun 15, 2017 Veloxis Increases Share Capital in Connection with Exercise of Warrants PDF 174.3 KB Add to Briefcase
Jun 6, 2017 Veloxis Pharmaceuticals A/S Announces Agreement with Chiesi Farmaceutici S.p.A. to Commercialize Envarsus XR in China PDF 176.0 KB Add to Briefcase
Jun 5, 2017 Veloxis Pharmaceuticals A/S and Endo Ventures Limited Jointly Announce Agreement for Paladin Labs Inc. to Commercialize Envarsus XR® in Canada PDF 194.4 KB Add to Briefcase
May 16, 2017 Veloxis Pharmaceuticals Announces Financial Results for the First Three Months of 2017 PDF 428.1 KB Add to Briefcase
Apr 30, 2017 Veloxis Announces the Total Number of Shares and Voting Rights in the Company as of 30 April 2017 PDF 206.4 KB Add to Briefcase
Apr 7, 2017 Veloxis Pharmaceuticals A/S - Passing of Annual General Meeting 2017 PDF 316.4 KB Add to Briefcase
Apr 4, 2017 Veloxis Increases Share Capital in Connection with Exercise of Warrants PDF 173.7 KB Add to Briefcase
Mar 31, 2017 Veloxis Announces the Total Number of Shares and Voting Rights in the Company as of 31 March 2017 PDF 207.2 KB Add to Briefcase
Mar 31, 2017 Veloxis Pharmaceuticals A/S Announces Agreement for Taiba Healthcare to Commercialize Envarsus XR in the Middle East and North Africa Region PDF 177.6 KB Add to Briefcase
Mar 28, 2017 Veloxis Increases Share Capital in Connection with Exercise of Warrants PDF 253.2 KB Add to Briefcase
Mar 20, 2017 Veloxis Increases Share Capital in Connection with Exercise of Warrants PDF 174.7 KB Add to Briefcase
Mar 16, 2017 Notice to Convene Annual General Meeting 2017  
Mar 16, 2017 Indkaldelse til ordinær generalforsamling  
Mar 1, 2017 Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program PDF 229.0 KB Add to Briefcase
Feb 28, 2017 Veloxis Pharmaceuticals Releases Annual Report for 2016 PDF 198.5 KB Add to Briefcase
Feb 28, 2017 Veloxis Pharmaceuticals Announces New Jersey Office Closure PDF 249.9 KB Add to Briefcase
Feb 23, 2017 Veloxis Pharmaceuticals A/S to Host Conference Call Announcing Annual Report 2016—Results from 1 January to 31 December, 2016 PDF 257.2 KB Add to Briefcase
Feb 8, 2017 Veloxis Pharmaceuticals Announces Amended and Restated Loan and Security Agreement PDF 251.0 KB Add to Briefcase
Jan 25, 2017 Veloxis Pharmaceuticals Announces Updated Financial Calendar for 2017 PDF 252.5 KB Add to Briefcase
Showing 1-26 of 26 Page: 1  
=add release to Briefcase